chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My husband had the shingles shots and He got shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: My husband had the shingles shots and He got shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 18-SEP-2023 This case was reported by a patient's wife via interactive digital media. The reporter reported that her husband received Shingles vaccine and experienced shingles, what a waste. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Alopecia Areata. Lost hair on both sides of head, about the size of a fist on each side, also losing hair along top front hair line and possibly under arms.
liver issues; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Dec2020 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIVER DISORDER (non-serious), outcome "recovering", described as "liver issues". The event "liver issues" required physician office visit.  Additional information: patient had suffered significant liver issues since receiving the first dose of the Covid vaccine in Dec2020. Patient's liver was still healing and patient still had checkups with a hepatologist at the (Facility Name withheld) in (City Name withheld). It was slowly starting to get better but patient was still not 100% back to normal by any means.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
10 days following Shingrix vaccine, I began to break out in rash on torso. It resembled Chickenpox spots exactly and continued to emerge over the next 4 or 5 days - eventually affecting torso, arms and legs. No fever or respiratory symptoms. Only the rash. Minor itching and tenderness. Rash is beginning to dry. Called pharmacist. They said this is a possible reaction. Went to see nurse practitioner. She was baffled - attempted to culture spots. Prescribed prednisone and antihistamine. I did not take the prednisone as it is not recommended for chickenpox and I?m certain that?s what this rash is, if not full blown. I had chickenpox as a 4 year old.  My main concern is how contagious I might be.
Approximately 8 to 10 hours after the 2nd in the series Pt had soreness at the arm.  The following a.m. the pain had increased and spread into the neck and upper back area.  Heavy fatigue throughout the day and evening.  High Fever started in the early afternoon of the 2nday post the shot.  Fever increased to 102. by 7 pm.
still testing positive; still testing positive; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient received BNT162b2 (BNT162B2), in Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 39 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "still testing positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that rebound with new symptoms on day 10, so far 6 days into rebound, still testing positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Localized itchy hives hours after receiving vaccine and going home. Made staff aware of adverse event 1 month later.
Initial report received from a consumer on 08 Apr 2010: This patient was vaccinated with first dose of RABAVERT (batch number unknown), (01ml, Intramuscular) on 22 Mar 2010 and second dose (01 ml, Intramuscular) on 29 Mar 2010 as part of pre-exposure series. The patient experienced intense migraine and symptoms worsened throughout the day where jaw pain was evident, accompanied by poor range of motion of the mandibular joint on 01 Apr 2010. The patients throat began to close up and the patient was rushed to the emergency room on 08 Apr 2010. It was reported that, intense migraine that was not alleviated with over the counter pain medications. the outcome of events were reported as condition unchanged. Follow up report received from a physician on 19 Apr 2010: the patient experienced L-TMJ (left temporomandibular joint arthralgia on 08 Apr 2010. Outcome of the events was reported as condition improving. The reporter's causality assessment for events were provided as not suspected.
Foot drop. Admitted to hospital. Left-side went numb. Treated for GBS.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: EN6199), in left arm, on 24Mar2021 as dose 2, single (Lot number: EP7534), in left arm, on 21Nov2021 as dose 3 (booster, single) (Lot number: FH8027), in left arm and on 03May2022 as dose 4 (booster, single) (Lot number: FJ4989) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN, start date: 04Jul2022. Past drug history included: Amoxicillin, reaction(s): "known allergies: Amoxicillin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "recovering" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Jul2022) Negative, notes: Negative test on day 6; (Jul2022) Unknown results, notes: Indication: Covid-19 treatment; (Jul2022) Positive, notes: Positive test still on day 12 (today). Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received antiviral COVID-19 treatment with Paxlovid from 05Jul2022 to 09Jul2022. The patient finished Paxlovid on day 5. Negative test on day 6. Symptoms returned with Paxlovid rebound on day 10. No fever, but stuffy nose and sore throat. Positive test still on day 12 (today), but symptoms were improving. Only treatment included Musinex and Azelistine spray.  No follow-up attempts are possible. No further information is expected.
This serious, medically confirmed report (initial receipt 09-JUL-2013) concerns a female patient who had a medical history of diabetes and unspecified drug reactions/allergies to CYMBALTA, DAYPRO, ZOLOFT. On an unspecified date, the patient received the swine flu vaccine (manufacturer and batch number not provided) as a  yearly flu shot. On an unspecified date, the patient developed temporary paralysis. Outcome was reported as recovered.
Patient received COVID booster dose, Requested Moderna. Patient stated he lost his vaccine card and asked if we could fill out the card info for the first two vaccines. Upon checking FL Shots it was discovered that he received Pfizer for his first two vaccines.
Patient received MMR and Tdap vaccination. Immediately following injection patient became dizzy and lost consciousness. Regained consciousness after 2 minutes. Vital signs stable. Observed in clinic for 1 hr and assessed by doctor. Neuro checks with vital signs stable. No localized reaction. Possible vagal response. No discomfort, no SOB or other symptoms.
First, patient had flu like symptoms and then he got a bad rash all over his chest and back, look like chicken pox. Now he is having chest pains.
painful teeth; This case was reported by a pharmacist via call center representative and described the occurrence of toothache in a male patient who received Herpes zoster (Shingrix) (batch number T79D7, expiry date 1st October 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 4th August 2020).   On 4th January 2021, the patient received the 2nd dose of Shingrix. On 6th January 2021, 2 days after receiving Shingrix, the patient experienced toothache. On an unknown date, the outcome of the toothache was unknown.   It was unknown if the reporter considered the toothache to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The experiencing reaction of painful teeth. Did not consent to follow-up.
Vaccine admin. 10/18/10 and has rash on shoulder & pain in shoulder area as of 11-2-10. Pt. said when he took band-aid off rash appeared and hasn't gone away.
Client recevied the COVID-19 vaccine on 1/5/21 by the Vaccine clinic. Client tested positive for COVID-19 by rapid testing on 1/21/21, with c/o hurting all over and loose stools.  She became non-verbal on 1/23/21 with poor intake.   On 1/24/21 at 0537 Client was unresponsive and without vital signs.  Orders were for DNR, and CPR was not initiated.
Awakened with petachiae on both arms, shoulders to wrists, across stomach,   and with a few on chest
Paralysis of left side of face, then right side the next day. Admitted to hospital 4/23/2010 and treated for Guillain Barre Syndrome.
The night I got the vaccine I had a weird thing happen with my heart rate. Just walking form my bed to the bathroom and my office, I was winded and my heart rate was elevated. My apple watch was reading 135 bpm. Then, my heart rate was bouncing around all over the place while I was at rest working at my desk. I also felt very tired. I decided not to move the next day except for when I had to. I took a shower and my heart rate was 169bpm. Then I felt like I had run a 5k in the dead of summer. I was so fatigued the rest of the day. This went on for multiple days. I did a telehealth with my doctor and she advised me that I was probably okay and gave me tips on how to lower my heart rate. She said if it does not get better, I should go to urgent care.  Today, I am feeling better but it still elevates a bit when I go on a walk.
Fatigue the day after injection.  I had to go back to bed and sleep for 3-4 hours.  After that I was fine.  The news said to report anything so I did
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Past drug history included: Tetracycline, reaction(s): "Known allergies: Tetracycline". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Soreness at injection site for two days,  severe muscle aches on day 2,  rash on chest, abdomen and upper part of legs on day 4.
Information has been received from a registered nurse referring to three unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown dates, three unspecified patients were vaccinated with three additional doses of improperly stored (Merck) VARIVAX (strength, dose, route, anatomical location, lot number and expiration date were not reported). No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of three reports received from the same reporter. Additional information has been requested.
On the morning of, Thursday 09/09/2021, at 0800 hours after working a graveyard shift, I went to the  Clinic in the hospital  for a regular annual checkup appointment at 0830. While the nurse took my vital signs, she offered me the SHINGRIX vaccine.  My wife had had both doses a couple of years ago, and we felt it was a good vaccine to get as we aged, so I said yes to the nurse. I received the first dose of the SHINGRIX vaccine at that time. I got home about 1100 hours.  I ate some lunch and went to bed with a sore left arm. I woke up earlier than normal to help cover a two-hour portion of a shift of a coworker who is out for a few days.  I felt a little dizzy as I got dressed and thought it was just from waking up. While I drove into work, I started to feel really sick, some flu like symptoms that I hadn't felt in over 5 years.  I actually don?t remember the last time I felt the way I was feeling.  I thought to myself that this was definitely connected to the SHINGRIX vaccine that I had earlier.  After I got to work, I signed into the logbook in the plant at 2200 hours.  I searched on the Internet and looked on the SHINGRIX website for side effects.   The SHINGRIX website and also the CDCs website; were nearly identical in noting the following side effects: Muscle Pain, Tiredness, Headache, Shivering, Fever, Upset stomach, Nausea, dizziness and a few other side effects listed.  I called the ER here and let them know I work here  on a graveyard shift and asked one of the nursing staff about the side effects of the SHINGRIX vaccine. They confirmed what the two websites were saying about the side effects.  They said I should go home immediately. Which I did. I felt like I was going to die. One concern I still have,  is the CDCs statement that the, "Symptoms went away on their own in about 2 to 3 days, but prevented those who experienced these side effects, from doing regular activities." However, I had to wait until 0200 hours in the morning to put in sick leave because of the sick leave I have used up to help my wife with eye surgery, the funeral for my mother and a bi-polar type 1 sister, who broke into our home, a few days ago while my wife was home.   There is enough going on in my life to have these side effects have such a severe effect on me, feeling as though I was about to die.  I still feel weak and am out of leave to take time off.
minor itchy spots torso and neck.  started 24 hours after shot.  first 7 days just 2 to 3 spots daily. days 9 thru 11 spots increased to about 8 to 10 daily.  These spots only lasted about a day. They did not break open, merely disappeared with no lasting marks.  There has been no new spots after day 14.  No medications was take, it was mild and I wanted to watch what would happen without treatment.
48 hours red, raised area 1 inch x 3 inches on Left Deltoid, malaise, diarrhea, nausea, stomach pain/body ache, rash on trunk, Left hip, headache.
tonic-clonic seizure Patient has a history of seizure disorders, dissociative convulsions, and head trauma.
This spontaneous report was received from a registered nurse concerning an unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in early July 2017, the patients were vaccinated an improperly stored doses of with M-M-R II  injection, lot number N013276, expiration date 21-JAN-2020 (dose and route of administration were  not reported) for prophylaxis. It was reported that sterile water diluent  properly stored was reconstituted with M-M-R II. The temperature of excursion with M-M-R II  was 47 to 77 Fahrenheit degrees during 5 minutes. No previous temperature of excursion was performed. The temperature of excursion was detected by a data logger. No adverse effects were reported. This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1709USA011512: US-009507513-1709USA011240:
Patient came in to be vaccinated when the needle was inserted and plunger pushed( needle was defective) 2/3 of the vaccine spilled out on to patients arm and the chair.  As a result the patient was issued another dose as per CDC guidelines in opposite arm for full dose.
This 3 year old patient was given a Pfizer 5-11 year old dose, 0.2 ml IM.
Child developed vomiting 1 week after injection for a few days. He also developed local reaction at injection site 1 week later with nodule and mild erythema. 13 days later developed 4 somewhat vesicular lesions on forehead. At time of evaluation, not fluid filled anymore so no fluid could be collected. He was seen by allergy for consult and they thought with timeline and description of lesions, could have been disseminated varicella lesions. His lesions resolved within a few days and he is now doing great and back to his baseline.
pt recvd flu vax & devel swelling w/in 2 hrs which measured 2" around the arm; reaction lasted 2 days;
Initial and follow-up information has been received from a registered nurse and a medical assistant concerning a 14 year old female patient who on 02-JAN-2012 at 08:39 A.M. was vaccinated with the third dose of GARDASIL (lot number 670050/1229AA) I.M., into left deltoid (dose not reported) at private doctor's office/hospital. It was reported that the refrigerator temperature fell below range, below 30 degrees F over 16 day period. The vaccine was compromised. There were no adverse events reported. The patient did not require ED/Doctor visit. This is one of several reports received from the same source. No further information is available.
Vaccination site pruritus; Vaccination site rash; Fever; Cough; Phlegm; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), PRODUCTIVE COUGH (Phlegm), VACCINATION SITE PRURITUS (Vaccination site pruritus), PYREXIA (Fever) and VACCINATION SITE RASH (Vaccination site rash) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A214A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced COUGH (Cough), PRODUCTIVE COUGH (Phlegm) and PYREXIA (Fever). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Vaccination site rash). At the time of the report, COUGH (Cough), PRODUCTIVE COUGH (Phlegm), VACCINATION SITE PRURITUS (Vaccination site pruritus), PYREXIA (Fever) and VACCINATION SITE RASH (Vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information were not provided. Patient had fever then a cough and a phlegm. She went to the emergency room and her arm started itching and had a rash at the injection site
Report of fever, with vomiting, swollen arm with a blister. No report of fever on 5/3/12. Instructed to see provider. Pt. seen Dr.
Patient presented with numbness and weakness of extremities, perioral area and perineum,. CSF found protein of 102 with 1 WBC, diagnosed with a Demyelinating inflammatory polyneuropathy (either AIDP or CIDP). Patient receiving treatment with IVIG with improvement in symptoms. At this point, still receiving IVIG, strength almost entirely back to normal with minimal numbness.
Fever, chills, insomnia, headache, vomiting (2 times)
Slow on set of another possible bout of myelitis.  Numbness, dizziness, headaches.
I was found unconscious in my living room recliner.  My daughter could not wake me up.  I had moments of incoherency and then would fall into unconsciousness.  I was transported to hospital by ambulance.  I was hospitalized for 2 days, my blood sugar was 59.  I was diagnosed as being in an altered mental state although they did know what my problem was.  I rebounded after treatment with fluids and was released two days later.
Fatigue; depression; body aches; This is a spontaneous report from a contactable consumer or other non hcp. A 68-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EL9265), dose 2 via an unspecified route of administration, administered in Arm Right on 13Feb2021 09:30 AM (Batch/Lot Number: EL9265) as DOSE 2, SINGLE for covid-19 immunisation (at the age of 68-year-old). The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of bnt162b2 on 23Jan2021 08:30 AM in Left arm for covid-19 immunisation. On 21Feb2021 patient experienced Fatigue, depression, and body aches. The patient did not received treatment. The outcome of the event was recovered.  No follow-up attempts are needed. No further information is expected.
Spoke with mom, she states pt had redness at injection site and red raised bumps on chest and arms which mom said looks like hives. Mom gave BENADRYL, pt went swimming. No SOB or follow-up appointment needed per mom. Within 3 hours rash was resolved. Today no redness at injection site or other adverse events noted. Pt is attending school today.
Pfizer was making people sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed, unknown manufacturer), for COVID-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Pfizer was making people sick".  Additional information: Age Group was reported as adult (18 to less than 65 years).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Left shoulder pain, unable to lift my arm, started shortly after I got Covid vaccine #1. on April 17.
Rash/itchy at injection site. Arm is warm and sore. Fever.
I have had cold sores herpes for 12 years.  Had a total of 2 outbreaks total until vaccination.  Now I?m having 1-12 outbreaks per months sometimes twice per week